Glial Fibrillary Acidic Protein (GFAP) is a cytoskeletal protein predominantly expressed in astrocytes, a type of glial cell found in the central nervous system (CNS). GFAP plays a crucial role in providing structural support to astrocytes and is involved in various cellular processes, including cell shape maintenance, migration, and response to injury or pathological conditions. As a key component of intermediate filaments, GFAP contributes to the formation of the astrocyte cytoskeleton, which is essential for maintaining the integrity and function of the CNS. Additionally, GFAP is implicated in regulating the interactions between astrocytes and neurons, as well as modulating the extracellular environment by regulating the release of various signaling molecules.
Activation of GFAP can occur through several mechanisms, primarily in response to cellular stress, injury, or pathological conditions. One common mechanism involves the activation of signaling pathways associated with cellular stress responses, such as the mitogen-activated protein kinase (MAPK) pathway and the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway. These pathways can be activated by various stimuli, including oxidative stress, inflammation, and mechanical injury, leading to the phosphorylation and subsequent activation of transcription factors that regulate GFAP gene expression. Furthermore, GFAP activation can be mediated by calcium signaling pathways, where increases in intracellular calcium levels trigger downstream signaling cascades that ultimately promote GFAP expression and cytoskeletal rearrangement. Additionally, growth factors and cytokines released in response to injury or inflammation can also stimulate GFAP expression and astrocyte activation. Overall, the activation of GFAP is a complex process involving the integration of multiple signaling pathways and cellular responses, ultimately leading to the adaptation of astrocytes to changing physiological or pathological conditions within the CNS.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Can induce differentiation in astrocytes and alter GFAP expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates cAMP levels, which can influence GFAP expression. | ||||||
Substance P | 33507-63-0 | sc-201169 | 1 mg | $56.00 | ||
A neuropeptide that might influence astrocytes and GFAP expression. | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $220.00 $645.00 $1000.00 $1500.00 $440.00 | 32 | |
Involved in astrocyte function and might influence GFAP levels. | ||||||